Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Topic or Issue
Home Search/Browse Subscriptions PDA Services My JCO Customer Service

Journal of Clinical Oncology, 2008 ASCO Annual Meeting Proceedings (Post-Meeting Edition).
Vol 26, No 15S (May 20 Supplement), 2008: 16132
© 2008 American Society of Clinical Oncology
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rivarola, E. J.
Right arrow Articles by Gercovich, F. G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Rivarola, E. J.
Right arrow Articles by Gercovich, F. G.

Abstract

Gonadal germinal testicular tumors (GGTT): The Henry Moores latest series

E. J. Rivarola, C. García Gerardi, D. Santillan, G. Martín Reinas, M. Abal, J. C. Calarame, E. Gil Deza, E. Morgenfeld and F. G. Gercovich

Instituto Oncológico Henry Moore, Ciudad de Buenos Aires, Argentina

16132

Background: Testicular cancer represents only 1% of all oncological diagnoses in men. It is, however, of peculiar importance, given that it is the most frequent solid tumor found in teenagers and young adults (age range: 15 to 35 years) andhas a high rate of cure. Objective: The aim of this study is to present and analyze the cohort of patients with a confirmed diagnosis of GGTT treated at our Institution. Material and Methods: Our institute’s database, which covers the past 10 years, was analyzed, and the patients diagnosed with GGTT were selected. Patients who had "extra-gonadal" tumors, were excluded from the present series. The patients were categorized in two different groups: "seminomatous" (S) and "non-seminomatous" (NS). The classification of the cases in risk groups was made following the International Consensus of the Collaborative Group. The risk groups were low, medium and high, based on two variables: the level of blood markers and site of metastasis. The treatment followed the guidelines of the NCCN. Results: The number of evaluable patients was 265. The main characteristics of the population are outlined in table 1: Conclusion: The GGTT are the most curable neoplasias amongst solid tumors. In our cohort we have found that the primary therapeutical objective (curability) has been reached, and correlates with the results that have been obtained by other prestigious international institutions. While this illness might not be frequent, it is very important considering the age range that encompasses.


View this table:
[in this window]
[in a new window]

 
Table 1: Characteristics of the population

 
No significant financial relationships to disclose.






About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions

Copyright © 2008 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
HighWire Press HighWire Press™ assists in the publication of JCO Online